Report Description
The global obesity treatment market is projected to register a robust CAGR during the forecast period, between 2021 and 2028. Obesity refers to a disease that involves an excess amount of fat in the body. This increases the risk of other health problems such as heart diseases, diabetes, high blood pressure, and certain cancers. Obesity treatment involves assessment and management of the disease. The treatment for obesity is a complex process but it starts mainly with a healthy lifestyle and exercise. The diet quality can be improved by maintaining a proper proportion of the food products and reducing the intake of food rich in sugar or fats. Medications are also used while maintaining a balanced diet. However, if diet, medications and exercise don’t curb the disease, then the chances for gastric balloon or surgery increases, in order to reduce stomach volume or length of the intestines that reduces the ability of the body to absorb nutrients from the food.
Market Trends, Drivers, Restraints, and Opportunities:
- Increasing government initiatives to spread awareness about fitness and healthy lifestyle is driving the market growth.
- High cost of surgeries and the risk of poor medical facilities and services, especially in low-income countries can create challenges for the growth of the market.
- Rising demand for minimal invasive surgeries, aggressive marketing strategies by key players in the market and reimbursement policies are spurring the market growth.
Scope of the report:
The report on the global obesity treatment market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Attributes | Details |
Report Title | Global Obesity Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year | 2020 |
Historic Data | 2018 & 2019 |
Forecast Period | 2021–2028 |
Segmentation | Lifestyle Changes (Dietary Changes and Exercise), Surgical and Implant Devices (Gastric Bypass Surgery, Gastric Band, Gastric Balloon, Electrical Stimulation Systems, and Gastric Emptying Systems), Medication Therapies (Combination Drug Therapies and Individual/Satiety Drugs) |
Regional Scope | Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
Report Coverage | Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
Obesity Treatment Market Segment Insights:
Dietary segment to grow at a robust pace during the forecast period
Based on lifestyle changes, the obesity treatment market can be segmented into dietary changes and exercise. The dietary segment is forecasted to account a large market share due to the focus of the people on improving their diet intake. The importance of maintaining a balanced diet and the intake of vital nutrients has been established by many health organisations as well as the government. Changes in the diet, by reducing the level of sugar or fatty foods can help in treatment of obesity. On the other hand, practicing exercises helps the body in defeating diseases and keeps the mind and body healthy.
Gastric bypass surgery segment to exhibit a high CAGR
On the basis of surgery and implant devices, the obesity treatment market can be divided into gastric bypass surgery, gastric balloon, gastric band, electrical stimulation systems, and gastric emptying systems. The gastric bypass surgery is anticipated to exhibit a high CAGR during the forecast period. Gastric bypass surgery is a preferred method for the treatment of obesity due to fast recovery time, improved psychological status, and improved longevity. A person with stage 2 diabetes or sleep apnea is qualified for a gastric bypass surgery.
Combination drug therapies segment to expand at a significant growth rate during the forecast period
In terms of medication therapies, the market can be divided into individual/satiety drugs and combination drug therapies. The combination drug therapies segment is projected to hold a major market share during the forecast period. This is due to the combined effect of therapy and rising cases of obesity. The composition of combination drugs propels the treatment process. However, the individual drugs segment is anticipated to expand at a steady rate owing to its low cost than the combination drug therapy.
North America to dominate the market
Based on regions, the obesity treatment market can be categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North American is projected to hold a significant market share due to the rising cases of obesity in the countries such as the US and Canada. Strong government support and growth in the obese population has further attributed to the growth of the market in the region. Key players are investing heavily in R&D projects for better medicines and therapies to ensure better results among patients. The rise in awareness about obesity and the commercialization of invasive surgeries has also aided to the growth of the market in North America.
Segments
By Lifestyle Changes
By Medication Therapies
- Combination Drug Therapies
- Individual/ Satiety Drugs
By Surgical and Implant Devices
- Gastric Bypass Surgery
- Gastric Band
- Gastric Balloon
- Electrical Stimulation Systems
- Gastric Emptying Systems
By Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
By Key Players
- NutriSystem Inc.
- Kellogg Company
- Ethicon Inc.
- Atkins Nutritionals Inc.
- Herbalife Ltd.
- Covidien plc
- Apollo Endosurgery
- Amer Sports
- Johnson Health Technology Ltd
Competitive Landscape
Key players in the obesity treatment market include NutriSystem Inc., Kellogg Company, Ethicon Inc., Atkins Nutritionals Inc., Herbalife Ltd., Covidien plc, Apollo Endosurgery, Amer Sports, and Johnson Health Technology Ltd. These players are actively engaged in several market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.
Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Obesity Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Obesity Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Obesity Treatment Market - Supply Chain
4.5. Global Obesity Treatment Market Forecast
4.5.1. Obesity Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Obesity Treatment Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Obesity Treatment Market Absolute $ Opportunity
5. Global Obesity Treatment Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Obesity Treatment Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Obesity Treatment Demand Share Forecast, 2019-2026
6. North America Obesity Treatment Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Obesity Treatment Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Obesity Treatment Demand Share Forecast, 2019-2026
7. Latin America Obesity Treatment Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Obesity Treatment Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Obesity Treatment Demand Share Forecast, 2019-2026
8. Europe Obesity Treatment Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Obesity Treatment Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Obesity Treatment Demand Share Forecast, 2019-2026
9. Asia Pacific Obesity Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Obesity Treatment Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Obesity Treatment Demand Share Forecast, 2019-2026
10. Middle East & Africa Obesity Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Obesity Treatment Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Obesity Treatment Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Obesity Treatment Market: Market Share Analysis
11.2. Obesity Treatment Distributors and Customers
11.3. Obesity Treatment Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. NutriSystem Inc.
11.4.2.
Kellogg Company
11.4.3.
Ethicon Inc.
11.4.4.
Atkins Nutritionals Inc.
11.4.5.
Herbalife Ltd.
11.4.6.
Covidien plc
11.4.7.
Apollo Endosurgery
11.4.8.
Amer Sports
11.4.9.
Johnson Health Technology Ltd.